Pharmacokinetics and Pharmacodynamics of Midazolam and Metabolites in Nonventilated Infants after Craniofacial Surgery

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Anesthesiology

• Publication date

  2006-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00000542-200612000-00013PMID 17122576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Propofol Pharmacokinetics and Pharmacodynamics for Depth of Sedation in Nonventilated Infants after Major Craniofacial Surgery

  2006cited by this paper
• A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels.

  2005cited by this paper
• PAEDIATRIC ANAESTHESIA Propofol 6% as sedative in children under 2 years of age following major craniofacial surgery

  2005cited by this paper
• Assessment of sedation levels in pediatric intensive care patients can be improved by using the COMFORT “behavior” scale*

  2005influential reference
• Pharmacodynamics of Midazolam in Pediatric Intensive Care Patients

  2005cited by this paper
• Bispectral index versus COMFORT score to determine the level of sedation in paediatric intensive care unit patients: a prospective study

  2004cited by this paper
• Developmental Expression of the Major Human Hepatic CYP3A Enzymes

  2003cited by this paper
• Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.

  2003cited by this paper
• Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients

  2003cited by this paper
• CYP3A5 variant allele frequencies in Dutch Caucasians.

  2002cited by this paper
• Contribution of midazolam and its 1-hydroxy metabolite to preoperative sedation in children: a pharmacokinetic-pharmacodynamic analysis.

  2002cited by this paper
• Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.

  2002cited by this paper
• An item analysis of the COMFORT scale in a pediatric intensive care unit

  2002cited by this paper
• Molecular Mechanisms of Polymorphic CYP3A7 Expression in Adult Human Liver and Intestine*

  2002cited by this paper
• Analgesic efficacy of rectal versus oral acetaminophen in children after major craniofacial surgery

  2001cited by this paper
• The Effect of Noise on the Bispectral Index During Propofol Sedation

  2001cited by this paper
• The Single‐Dose Pharmacokinetics of Midazolam and Its Primary Metabolite in Pediatric Patients after Oral and Intravenous Administration

  2001cited by this paper
• The Differences in the Bispectral Index Between infants and Children During Emergence from Anesthesia After Circumcision Surgery

  2001cited by this paper
• The reliability and validity of the COMFORT scale as a postoperative pain instrument in 0 to 3‐year‐old infants

  2000cited by this paper
• CYP3A4-V polymorphism detection by PCR-restriction fragment length polymorphism analysis and its allelic frequency among 199 Dutch Caucasians.

  2000cited by this paper
• Population pharmacokinetic modeling in very premature infants receiving midazolam during mechanical ventilation: midazolam neonatal pharmacokinetics.

  1999cited by this paper
• Paediatric intensive care.

  1999cited by this paper
• Population Pharmacokinetics of Midazolam Administered by Target Controlled Infusion for Sedation following Coronary Artery Bypass Grafting

  1998cited by this paper
• Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam.

  1998cited by this paper
• Clinical Pharmacology of Midazolam in Infants and Children

  1998cited by this paper
• Population Pharmacodynamics of Midazolam Administered by Target Controlled Infusion in SICU Patients after CABG Surgery

  1998cited by this paper
• Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth.

  1997cited by this paper
• Steady-State Plasma Concentrations of Midazolam in Critically Ill Infants and Children

  1996cited by this paper
• Prolonged sedation due to accumulation of conjugated metabolites of midazolam.

  1995cited by this paper
• Assessing distress in pediatric intensive care environments: the COMFORT scale.

  1992cited by this paper
• Pharmacokinetic‐pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite α‐hydroxymidazolam in healthy volunteers

  1992cited by this paper
• A pharmacokinetic study of midazolam in paediatric patients undergoing cardiac surgery.

  1988cited by this paper
• Comparison of the effects of intravenously administered midazolam, triazolam and their hydroxy metabolites.

  1983cited by this paper
• Excretion and metabolism of 14C-midazolam in humans following oral dosing.

  1981cited by this paper
• Paediatric intensive care.

  1973influential reference

• Advances in pharmacokinetic-pharmacodynamic modeling for anesthesia, 1987-2024: a review.

  2026cites this paper
• Pharmacokinetic and Pharmacodynamic Modeling of Clonidine and Midazolam for Sedation in Pediatric Intensive Care

  2025cites this paper
• Effect of Extracorporeal Membrane Oxygenation Flow Rate on Midazolam Clearance: A Population Pharmacokinetic Study

  2025cites this paper
• Characterization of Pediatric Rectal Absorption, Drug Disposition, and Sedation Level for Midazolam Gel Using Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling.

  2024cites this paper
• Safety, Pharmacokinetics, and Pharmacodynamics of Midazolam Gel After Rectal Administration in Healthy Chinese Subjects

  2023cites this paper
• Pharmacokinetic pharmacodynamic modeling of analgesics and sedatives in children.

  2023cites this paper
• NEUROCOV/PSYCCOV: Neuropsychiatric Phenomena in COVID-19-Exposing Their Hidden Essence and Warning against Iatrogenesis

  2021cites this paper
• Re-Examining the Impact of Minimal Scans in Liquid Chromatography-Mass Spectrometry Analysis.

  2021cites this paper
• Midazolam Infusion and Disease Severity Affect the Level of Sedation in Children: A Parametric Time-to-Event Analysis

  2021cites this paper
• Quantification of Pain and Distress.

  2021cites this paper
• Exploring the Relationship Between Morphine Concentration and Oversedation in Children After Cardiac Surgery

  2020cites this paper
• Electronic Health Record–Embedded Decision Support Platform for Morphine Precision Dosing in Neonates

  2020cites this paper
• Sedation With Midazolam After Cardiac Surgery in Children With and Without Down Syndrome: A Pharmacokinetic-Pharmacodynamic Study.

  2020cites this paper
• Midazolam Dose Optimization in Critically Ill Pediatric Patients With Acute Respiratory Failure: A Population Pharmacokinetic-Pharmacogenomic Study

  2019cites this paper
• Neonatal Pharmacogenetics

  2019cites this paper
• Maturation of midazolam clearance in critically ill children with severe bronchiolitis: a population pharmacokinetic analysis.

  2019cites this paper
• Benzodiazepine in der Anästhesiologie

  2019cites this paper
• Prolonged Anesthetic Recovery after Continuous Infusion of Midazolam in 2 Domestic Cats (Felis catus).

  2019cites this paper
• Characterization of Intestinal and Hepatic CYP3A-Mediated Metabolism of Midazolam in Children Using a Physiological Population Pharmacokinetic Modelling Approach

  2018cites this paper
• Development and validation of a sensitive assay for analysis of midazolam, free and conjugated 1-hydroxymidazolam and 4-hydroxymidazolam in pediatric plasma: Application to Pediatric Pharmacokinetic Study.

  2017cites this paper
• Pharmacokinetic–Pharmacodynamic Modelling of Anesthetic Drugs

  2017cites this paper
• Population pharmacodynamic modelling of midazolam induced sedation in terminally ill adult patients

  2017cites this paper
• Predicting CYP3A‐mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure

  2017cites this paper
• Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?

  2016cites this paper
• Variation in clearance and invasiveness of pharmacokinetic studies in children

  2016cites this paper
• Effect of local food on lumefantrine bioavailability and population pharmacokinetics in Ugandan children with malaria

  2016influential citation
• Pain in Intellectually Disabled Children: Towards Evidence-Based Pharmacotherapy?

  2015cites this paper
• Adverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis

  2015cites this paper
• Concepts and applications for evidence-based dosing in morbidly obese patients before and after weight loss surgery

  2015cites this paper
• Clinical Pharmacology of Midazolam in Neonates and Children: Effect of Disease—A Review

  2014cites this paper
• Developmental pharmacokinetics in pediatric populations.

  2014cites this paper
• Pharmacokinetics in children with liver disease : can ex vivo obtained population-specific CYP450 characteristics bridge the knowledge gap?

  2014cites this paper
• A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo Data

  2014cites this paper
• Inter-individual variation in midazolam clearance in children

  2014cites this paper
• APPLICATIONS OF PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELLING TO PREDICTION OF THE LIKELIHOOD OF METABOLIC DRUG INTERACTIONS IN PAEDIATRIC POPULATION AND STUDYING DISPARITIES IN PHARMACOKINETICS BETWEEN CHILDREN AND ADULTS

  2014cites this paper
• Prediction of heptatic and renal clearance in pediatric populations: A "bottom-up" approach versus "top-down" recognition of covariates

  2013cites this paper
• Maturation of cytochrome P450 3A mediated drug metabolism: Towards individualized dosing in children

  2013influential citation
• The influence of morbid obesity on the pharmacokinetics and pharmacodynamics of drugs in adolescents and adults : focus on propofol and nadroparin.

  2013cites this paper
• Developmental Changes in the Expression and Function of Cytochrome P450 3A Isoforms: Evidence from In Vitro and In Vivo Investigations

  2013cites this paper
• Erratum to: A Novel Maturation Function for Clearance of the Cytochrome P450 3A Substrate Midazolam from Preterm Neonates to Adults

  2013influential citation
• Novel approach to characterize developmental changes in pharmacokinetics across the human lifespan : application to the prediction of clearance in children

  2013cites this paper
• Assessing circadian rhythms during prolonged midazolam infusion in the pediatric intensive care unit (PICU) children

  2013influential citation
• A Novel Maturation Function for Clearance of the Cytochrome P450 3A Substrate Midazolam from Preterm Neonates to Adults

  2013cites this paper
• Growing up with midazolam in the neonatal and pediatric intensive care.

  2012cites this paper
• Propofol clearance in morbidly obese children and adolescents: influence of age and body size.

  2012cites this paper
• Does postoperative 'M' technique massage with or without mandarin oil reduce infants' distress after major craniofacial surgery?

  2012cites this paper
• Propofol Clearance in Morbidly Obese Children and Adolescents

  2012cites this paper
• Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models.

  2012cites this paper
• Critical Illness Is a Major Determinant of Midazolam Clearance in Children Aged 1 Month to 17 Years

  2012influential citation
• A maturation model for midazolam clearance

  2011cites this paper
• Pharmacokinetic design optimization in children and estimation of maturation parameters: example of cytochrome P450 3A4

  2011influential citation
• The effect of inflammation on drug metabolism: a focus on pediatrics.

  2011cites this paper
• Pharmacokinetic design optimization in children and estimation of maturation parameters : example of cytochrome P 450 3 A 4

  2011influential citation
• Prediction of drug clearance in children 3 months and younger: an allometric approach

  2010cites this paper
• The role of population PK–PD modelling in paediatric clinical research

  2010cites this paper
• Electroencephalographic Seizures After Neonatal Cardiac Surgery with High-Flow Cardiopulmonary Bypass

  2010cites this paper
• Quantification of midazolam, morphine and metabolites in plasma using 96-well solid-phase extraction and ultra-performance liquid chromatography-tandem mass spectrometry.

  2010cites this paper
• Interspecies Scaling for the Prediction of Drug Clearance in Children

  2010cites this paper
• Population Pharmacokinetics of Midazolam and Its Metabolites during Venoarterial Extracorporeal Membrane Oxygenation in Neonates

  2010cites this paper
• Challenges for drug studies in children: CYP3A phenotyping as example.

  2009cites this paper
• Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling.

  2009cites this paper
• Facilitation of Drug Evaluation in Children by Population Methods and Modelling

  2008cites this paper